These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8249607)

  • 1. [Effect of seleno-organic compounds on leukotriene B4 biosynthesis].
    Liu DP; Cheng GF; Bai JY; Guo ZR; Zhu XY
    Yao Xue Xue Bao; 1993; 28(6):472-6. PubMed ID: 8249607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous induction of interferon gamma and tumor necrosis factor alpha by different seleno-organic compounds in human peripheral blood leukocytes.
    Piasecki E; Inglot AD; Zielińska-Jenczylik J; Młochowski J; Syper L
    Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):229-34. PubMed ID: 1300988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seleno-organic compounds induce interferon and tumor necrosis factor in human but not in rat or mouse lymphoid cells.
    Inglot AD; Piasecki E; Zaczyńska E; Zielińska-Jenczylik J
    Arch Immunol Ther Exp (Warsz); 1992; 40(2):169-73. PubMed ID: 1284366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ebselen is a specific inhibitor of LTB4-mediated migration of human neutrophils.
    Patrick RA; Peters PA; Issekutz AC
    Agents Actions; 1993 Nov; 40(3-4):186-90. PubMed ID: 8023742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seleno-organic compounds as immunostimulants: an approach to the structure-activity relationship.
    Inglot AD; Młochowski J; Zielińska-Jenczylik J; Piasecki E; Ledwoń TK; Kloc K
    Arch Immunol Ther Exp (Warsz); 1996; 44(1):67-75. PubMed ID: 8874773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebselen has dehydroascorbate reductase and thioltransferase-like activities.
    Jung CH; Washburn MP; Wells WW
    Biochem Biophys Res Commun; 2002 Mar; 291(3):550-3. PubMed ID: 11855823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ebselen: a new approach to the inhibition of peroxide-dependent inflammation.
    Parnham MJ; Leyck S; Kuhl P; Schalkwijk J; van den Berg WB
    Int J Tissue React; 1987; 9(1):45-50. PubMed ID: 3036734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reaction of ebselen with peroxynitrite.
    Masumoto H; Sies H
    Chem Res Toxicol; 1996; 9(1):262-7. PubMed ID: 8924601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel biologically active seleno-organic compound--V. Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase.
    Safayhi H; Tiegs G; Wendel A
    Biochem Pharmacol; 1985 Aug; 34(15):2691-4. PubMed ID: 2990494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisecretory and antiulcer effects of ebselen, a seleno-organic compound, in rats.
    Tabuchi Y; Kurebayashi Y
    Jpn J Pharmacol; 1993 Mar; 61(3):255-7. PubMed ID: 8483303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of the inhibition of hog gastric H+,K(+)-ATPase by the seleno-organic compound ebselen.
    Tabuchi Y; Ogasawara T; Furuhama K
    Arzneimittelforschung; 1994 Jan; 44(1):51-4. PubMed ID: 8135879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ebselen protects mice against T cell-dependent, TNF-mediated apoptotic liver injury.
    Tiegs G; Küsters S; Künstle G; Hentze H; Kiemer AK; Wendel A
    J Pharmacol Exp Ther; 1998 Dec; 287(3):1098-104. PubMed ID: 9864298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system.
    Posser T; Kaster MP; Baraúna SC; Rocha JB; Rodrigues AL; Leal RB
    Eur J Pharmacol; 2009 Jan; 602(1):85-91. PubMed ID: 19026628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ebselen on adenine nucleotide hydrolysis by platelets from adult rats.
    Fürstenau CR; Spier AP; Rücker B; Luisa Berti S; Battastini AM; Sarkis JJ
    Chem Biol Interact; 2004 Jun; 148(1-2):93-9. PubMed ID: 15223359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of leukotriene B4 formation by Ebselen: a novel approach to antiinflammatory therapy.
    Kuhl P; Borbe HO; Römer A; Fischer H; Parnham MJ
    Agents Actions; 1986 Jan; 17(3-4):366-7. PubMed ID: 3008531
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinetic studies of the radical-scavenging activity of ebselen, a seleno-organic compound.
    Fujisawa S; Kadoma Y
    Anticancer Res; 2005; 25(6B):3989-94. PubMed ID: 16309189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protection of ebselen on oxygen free radical-induced lipid peroxidation damage of cultured rat cortical neuron and cortical mitochondria].
    Tan YX; Li WH; Jiang YY; Tao XB; Chen WP
    Yao Xue Xue Bao; 1997; 32(3):166-70. PubMed ID: 11327014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of ebselen on compound 48/80- and anti-IgE-induced histamine release from rat peritoneal mast cells.
    Tchoumkeu-Nzouessa GC; Rebel G
    Biochem Pharmacol; 1998 Dec; 56(11):1525-8. PubMed ID: 9827587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Selenization of salicylic acid derivatives yielded isoform-specific 5-lipoxygenase inhibitors.
    Yu SC; Kuhn H; Daniliuc CG; Ivanov I; Jones PG; du Mont WW
    Org Biomol Chem; 2010 Feb; 8(4):828-34. PubMed ID: 20135040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Benzisoselenazolinones and their derivatives, a new series of anti-inflammatories and antioxidants].
    Renson M; Dereu N
    J Pharm Belg; 1990; 45(5):322-30. PubMed ID: 2086756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.